STRIDE INC (LRN)

US86333M1080 - Common Stock

57.26  -0.31 (-0.54%)

After market: 57.26 0 (0%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to LRN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 73.19. This target is 27.81% above the current price.
LRN was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about LRN.
In the previous month the buy percentage consensus was at a similar level.
LRN was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 57.2665.6574.9773.1978.75 - 14.65% 30.93% 27.81% 37.53%
Up and Down Grades
Date Firm Action Rating
2024-04-17 Barrington Research Maintains Outperform -> Outperform
2024-01-29 Citigroup Maintains Buy -> Buy
2024-01-25 BMO Capital Maintains Outperform -> Outperform
2024-01-24 Barrington Research Maintains Outperform -> Outperform
2024-01-24 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-12-04 Barrington Research Reiterate Outperform -> Outperform
2023-11-16 BMO Capital Maintains Outperform -> Outperform
2023-11-16 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-10-26 BMO Capital Maintains Outperform -> Outperform
2023-10-25 Barrington Research Maintains Outperform -> Outperform
2023-10-25 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-08-16 Barrington Research Reiterate Outperform -> Outperform
2023-08-16 BMO Capital Maintains Outperform -> Outperform
2023-08-16 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-04-26 Morgan Stanley Maintains Equal-Weight
2023-04-14 Barrington Research Reiterate Outperform
2023-03-10 Morgan Stanley Downgrade Overweight -> Equal-Weight
2023-01-26 BMO Capital Maintains Outperform
2023-01-25 Barrington Research Reiterate Outperform
2023-01-25 Morgan Stanley Maintains Overweight
2023-01-04 Morgan Stanley Maintains Overweight
2022-10-27 BMO Capital Maintains Outperform
2022-10-27 Morgan Stanley Maintains Overweight
2022-09-27 Morgan Stanley Maintains Overweight
2022-08-25 Morgan Stanley Upgrade Equal-Weight -> Overweight
2022-08-10 Morgan Stanley Maintains Equal-Weight
2022-07-20 Morgan Stanley Maintains Equal-Weight
2022-04-20 Morgan Stanley Maintains Equal-Weight
2022-01-26 Morgan Stanley Maintains Equal-Weight
2022-01-05 Morgan Stanley Maintains Equal-Weight